Vipin K. Garg - Aug 30, 2022 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
President and CEO, Director
Signature
/s/ Kent A. Tapper, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
Aug 30, 2022
Transactions value $
-$457,275
Form type
4
Date filed
9/1/2022, 04:05 PM
Previous filing
Aug 12, 2022
Next filing
Oct 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Tax liability -$57K -3.01K -1.16% $18.94 257K Aug 30, 2022 Direct F1
transaction ALT Common Stock, par value $0.0001 Sale -$400K -20K -7.79% $20.02 237K Aug 31, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting transaction: Shares surrendered to the Issuer solely to cover taxes associated with vesting of restricted stock.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.19, inclusive. The reporting person undertakes to provide to Altimmune, Inc., any security holder of Altimmune, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.